RainDance Technologies' ThunderBolts Myeloid Panel

RainDance Technologies has launched its ThunderBolts Myeloid Panel, a next-generation sequencing research assay to detect and cost-effectively analyze genetic mutations associated with acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, and other myeloid cancers. The panel is a pre-validated assay for researching mutations and hotspots in 49 genes implicated in the causation, prognosis, and recurrence of certain blood and bone marrow cancers.